Skip to main content
. 2024 Mar 18;6(2):dlae045. doi: 10.1093/jacamr/dlae045

Figure 1.

Figure 1.

Flowchart of patient inclusion with consecutive subdivisions in patients with lower-than-target range, in-target range or higher-than-target range consecutive percentages of ECMO, renal replacement therapy and immunosuppression (IS)/transplantation (Tx) as well as description of the longitudinal course of therapy.